Abstract: A wall framing system for supporting an interior wall in spaced proximity to an exterior wall includes one or more stud members extending between upper and lower frame channel members, which are configured to self-locate in relation to the exterior wall in a manner which establishes a moisture and air barrier between the exterior wall and the interior wall supported by the wall framing system. The interior wall supported by the wall framing system is resistant to moisture degradation, and maintains desired R-value insulation properties throughout the wall.

Abstract: A wall framing system for supporting an interior wall in spaced proximity to an exterior wall includes one or more stud members extending between upper and lower frame channel members, which are configured to self-locate in relation to the exterior wall in a manner which establishes a moisture and air barrier between the exterior wall and the interior wall supported by the wall framing system. The interior wall supported by the wall framing system is resistant to moisture degradation, and maintains desired R-value insulation properties throughout the wall.

Abstract: A wall framing system for supporting an interior wall in spaced proximity to an exterior wall includes one or more stud members extending between upper and lower frame channel members, which are configured to self-locate in relation to the exterior wall in a manner which establishes a moisture and air barrier between the exterior wall and the interior wall supported by the wall framing system. The interior wall supported by the wall framing system is resistant to moisture degradation, and maintains desired R-value insulation properties throughout the wall.

Abstract: A wall framing system for supporting an interior wall in spaced proximity to an exterior wall includes one or more stud members extending between upper and lower frame channel members, which are configured to self-locate in relation to the exterior wall in a manner which establishes a moisture and air barrier between the exterior wall and the interior wall supported by the wall framing system. The interior wall supported by the wall framing system is resistant to moisture degradation, and maintains desired R-value insulation properties throughout the wall.

Abstract: This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure wherein R1, R2, R3, R4, R5, R6, R7, W, Y, and Z are defined herein; or a pharmaceutically acceptable salt thereof.

Abstract: This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure wherein R1, R2, R3, R4, R5, R6, R7, and R8 are each, independently, acyl of 2–7 carbon atoms, haloacyl of 2–7 carbon atoms, nitroacyl of 2–7 carbon atoms, cyanoacyl of 2–7 carbon atoms, trifluoromethylacyl of 3–8 carbon atoms, benzoyl, or —SO3H; R9 is hydrogen, CN, NO2, halo, CF3, alkyl of 1–6 carbon atoms, or alkoxy of 1–6 carbon atoms; R10 is hydrogen, —NO2, —NHR11, —NHR13, —N(R13)2, —NCH3R13, —NHCO2alkyl, wherein the alkyl moiety contains 1–6 carbon atoms, alkylsulfonamide of 1 to 4 carbon atoms, Z is O or S; R11 is an ?-amino acid in which the ? carboxyl group forms an amide with the nitrogen of R10, wherein if said amino acid is glutamic acid or aspartic acid, the non-? carboxylic acid is an alkyl ester in which the alkyl moiety contains from 1–6 carbon atoms; R12 is hydrogen, CN, NO2, halo, CF3, alkyl of 1–6 carbon atoms, alkoxy of 1–6 carbon atoms, acyl of 2–7 carbon atoms, or benzoyl;

Abstract: This invention provides compounds of Formula I having the structure or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.

Abstract: This invention provides compounds of Formula I having the structure 1

Abstract: This invention provides compounds of formula I having the structure wherein: B, D, C, and R1 as defined herein.

Abstract: This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure 1

Abstract: This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure wherein R1-R13 are as defined herein.

Abstract: This invention provides compounds of Formula I having the structure 1

Abstract: This invention provides compounds of Formula I having the structure wherein: B, C, D, and R1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.

Abstract: This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure with the variables defined herein.

Abstract: This invention provides compounds of Formula I having the structure 1

Abstract: This invention provides compounds of Formula I having the structure wherein: B, C, D, and R1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.